We are very proud of the ongoing work we have done and available online, offering the first ever single molecule detection of genomic and proteomic markers with the same platform SiMBiT for early detection of pancreatic cancer.
We are very proud of the ongoing work we have done and available online, offering the first ever single molecule detection of genomic and proteomic markers with the same platform SiMBiT for early detection of pancreatic cancer.
This project has received funding from the European Union’s
Horizon 2020 research and innovation programme under
grant agreement No 824946
The website SIMBIT is the property of the company name Efficient Innovation, registered with the RCS under number 417 879 509
Publication Director: Marc Delage
This website was created by the agency ML-COM
The publisher undertakes to respect all laws concerning the establishment and operation of an Internet site.
The information you enter will be saved. They will be analyzed and forwarded to relevant departments for the needs of internal management.
This information will be communicated to the company providers for the execution of work performed on its behalf.
The law "and Freedoms" of 06/01/1978 gives you the benefit of a right to access, correct and delete the personal data you provide.
If you want to exercise this right, please report it to us by mail, stating your name and address to:
SIMBIT
Efficient Innovation
29 rue Saint Lazare – 75009 Paris
France
Or by e-mail at the following address: si AT efficient-innovation.com
